tiprankstipranks
Trending News
More News >
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
India Market

Sun Pharma Advanced Research Co. Ltd. (SPARC) Income Statement

Compare
1 Followers

Sun Pharma Advanced Research Co. Ltd. Income Statement

Last quarter (Q4 2025), Sun Pharma Advanced Research Co. Ltd.'s total revenue was ₹271.90M, an increase of 64.19% from the same quarter last year. In Q4, Sun Pharma Advanced Research Co. Ltd.'s net income was ₹-597.70M. See Sun Pharma Advanced Research Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 717.70M₹ 755.45M₹ 2.31B₹ 1.37B₹ 2.53B
Gross Profit
₹ 486.50M₹ -1.24B₹ 592.00M₹ 105.52M₹ 465.55M
Operating Expenses
₹ 3.27B₹ 2.88B₹ 2.93B₹ 2.07B₹ 1.92B
Depreciation and Amortization
₹ 123.90M₹ 125.11M₹ 117.71M₹ 101.62M₹ 109.23M
EBITDA
₹ -3.23B₹ -3.73B₹ -2.03B₹ -1.80B₹ -1.30B
Operating Income
₹ -2.78B₹ -4.12B₹ -2.15B₹ -1.97B₹ -1.46B
Other Income/Expenses
₹ -648.00M₹ 246.72M₹ 10.61M₹ -73.23M₹ -54.37M
Pretax Income
₹ -3.43B₹ -3.87B₹ -2.23B₹ -2.03B₹ -1.51B
Net Income
₹ -3.43B₹ -3.87B₹ -2.23B₹ -2.03B₹ -1.51B
Per Share Metrics
Basic EPS
₹ -10.55₹ -11.93₹ -7.82₹ -7.73₹ -5.77
Diluted EPS
₹ -10.55₹ -11.93₹ -7.82₹ -7.73₹ -5.77
Weighted Average Shares Outstanding
324.65M 324.57M 284.70M 263.14M 262.05M
Weighted Average Shares Outstanding (Diluted)
324.65M 324.52M 284.70M 263.14M 262.05M
Currency in INR

Sun Pharma Advanced Research Co. Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis